Latest Articles
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - NTB Kommunikasjon
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 NTB Kommunikasjon
Published: June 14, 2026, 10:05 p.m.
Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers - Medical News Bulletin
Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers Medical News Bulletin
Published: June 11, 2026, 2:44 p.m.
GLP-1 RAs Help Reduce Obesity Related Cancers - Medical News Bulletin
GLP-1 RAs Help Reduce Obesity Related Cancers Medical News Bulletin
Published: June 11, 2026, 2:37 p.m.
Raising awareness for ovarian, endometrial cancers | 11 TV Hill - WBAL-TV
Raising awareness for ovarian, endometrial cancers | 11 TV Hill WBAL-TV
Published: June 2, 2026, 1:07 p.m.
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers - OncLive
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers OncLive
Published: May 30, 2026, 9:59 p.m.
Roles of Goserelin in Gynecological Disorders.
Goserelin is a gonadotropin-releasing hormone (GnRH) agonist with a long history of clinical application and well-established efficacy and safety profile. Its mechanism of action centers on sustained GnRH receptor desensitization, …
Published: May 27, 2026, midnight
New drug approach offers hope for patients with recurrent aggressive cancers - AOL.com
New drug approach offers hope for patients with recurrent aggressive cancers AOL.com
Published: May 25, 2026, 7:45 a.m.
New drug approach offers hope for patients with recurrent aggressive cancers - MSN
New drug approach offers hope for patients with recurrent aggressive cancers MSN
Published: May 24, 2026, 10:05 p.m.
New drug approach offers hope for patients with recurrent aggressive cancers - Fox News
New drug approach offers hope for patients with recurrent aggressive cancers Fox News
Published: May 20, 2026, 11 a.m.
Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.
Endometriosis, particularly ovarian endometrioma, is associated with a 2-fold increased risk of ovarian cancer (OC), especially the clear cell and endometrioid subtypes. However, the absolute lifetime risk of OC in …
Published: May 17, 2026, midnight
Link copied to clipboard!